0000792977-19-000075.txt : 20190412 0000792977-19-000075.hdr.sgml : 20190412 20190412162810 ACCESSION NUMBER: 0000792977-19-000075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190410 FILED AS OF DATE: 20190412 DATE AS OF CHANGE: 20190412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Phillips Anne M. CENTRAL INDEX KEY: 0001627680 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 19746574 MAIL ADDRESS: STREET 1: C/O TREVENA, INC. STREET 2: 1018 WEST 8TH AVENUE CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 6174983300 MAIL ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 4 1 wf-form4_155510087651744.xml FORM 4 X0306 4 2019-04-10 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001627680 Phillips Anne M. C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451 1 0 0 0 Common Stock 2019-04-10 4 A 0 564 A 564 D Stock Option (Right to Buy) 12.92 2019-04-10 4 A 0 6000 A 2029-04-10 Common Stock 6000.0 6000 D Stock Option (Right to Buy) 12.92 2019-04-10 4 A 0 1200 A 2029-04-10 Common Stock 1200.0 1200 D Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan, as amended (the "Plan") that will vest on May 1, 2019; however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer. Not applicable. Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twenty-four equal monthly installments over two years from the date of grant. Grant of stock option pursuant to the Plan. This option will vest and become exercisable on May 1, 2019. Nancy R. Smith, attorney-in-fact 2019-04-12